Compare Iovance Biotherapeutics Inc. Common Stock (IOVA) vs MKS Instruments (MKSI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Iovance Biotherapeutics Inc. Common Stock vs MKS Instruments — how do they compare? Iovance Biotherapeutics Inc. Common Stock trades at $14.62 (market cap $6.04B), while MKS Instruments trades at $264.5 (market cap $17.61B). The key difference: MKS Instruments is far larger — about 2.9× Iovance Biotherapeutics Inc. Common Stock's market cap, and MKS Instruments pays a 0.38% dividend while Iovance Biotherapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Iovance Biotherapeutics Inc. Common Stock for 0 Days and MKS Instruments for 7 Days on average.
| IOVA | MKSI | |
|---|---|---|
Market Cap | $6.04B | $17.61B |
Volume | 14,805,993 | 1,275,355 |
Sector | Health | Technology |
52-Week High | $14.82 | $444.80 |
52-Week Low | $1.81 | $121.26 |
Typical Hold Time | 0 Days | 7 Days |
Enterprise Value | $5.97B | $21.18B |
Dividend Yield | — | 0.38% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Iovance Biotherapeutics Inc. Common Stock
Iovance Biotherapeutics develops cell therapies for cancer. Its approach uses tumor-infiltrating lymphocytes, or TIL, to target solid tumors.
Read more on IOVA →About MKS Instruments
MKS develops instruments, systems, and process control solutions for advanced manufacturing. Its technologies serve semiconductor manufacturing, electronics and packaging, photonics, and specialty industrial applications.
Read more on MKSI →
